SCHEMBL5378937

SCHEMBL5378937

CCCCCCCCCCc1cccc(O)c1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 7/20 1.00
MCL1 Q07820 7/20 1.00
BCL2L1 Q07817 6/20 1.00
BAK1 Q16611 6/20 1.00
KAT8 Q9H7Z6 3/20 1.00
PPARA Q07869 3/20 1.00
SAE1 Q9UBE0 2/20 1.00
EP300 Q09472 2/20 1.00
KAT5 Q92993 2/20 1.00
PPARG P37231 2/20 1.00
KAT2A Q92830 1/20 1.00
KAT2B Q92831 1/20 1.00
F7 P08709 3/20 0.84
F3 P13726 3/20 0.84
MMP2 P08253 2/20 0.84
KDM4E B2RXH2 1/20 0.84
MAPT P10636 1/20 0.84
ALOX15 P16050 1/20 0.84
ECE1 P42892 1/20 0.84
SGMS1 Q86VZ5 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2558603 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
Ginkgolic Acid 13:0 SCHEMBL20298323 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL10877233 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
Anacardic Acid SCHEMBL627981 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL5379149 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL4248799 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL5378991 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL16237264 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL2126888 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8
Anacardic Acid SCHEMBL29408556 1.00 BID (1.00) BIDMCL1BCL2L1BAK1KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196214-B2 Process for arylamine production XEROX CORPORATION (US) 2007-03-27 US claimed
US-20060111582-A1 Process for arylamine production XEROX CORPORATION (US) 2006-05-25 US claimed
JP-6271502-A None JP disclosed
EP-1470108-B1 1,4-DIHYDROPYRIDINE AND PYRIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS VITTAL MALLYA SCIENT RES FOUNDATION (IN) 2016-08-24 EP disclosed
US-9149019-B2 Method of eliminating cat urine odor JMR, LC (US) 2015-10-06 US disclosed
US-20130323194-A1 METHOD OF ELIMINATING CAT URINE ODOR CO2 TECHNOLOGIES, INC. (US) 2013-12-05 US disclosed
US-7196214-B2 Process for arylamine production XEROX CORPORATION (US) 2007-03-27 US disclosed
US-20070066170-A1 CO2 GENERATING ABSORBENT PADS CO2 TECHNOLOGIES, INC. (US) 2007-03-22 US disclosed
US-7189666-B2 CO2 generating absorbent pads CO2 TECHNOLOGIES (US) 2007-03-13 US disclosed
US-7160939-B2 Preservatives; mixture of carbon dioxide in polymer matrix; mixture containing citric acid, calcium carbonate and low density polyethylene CO2 TECHNOLOGIES, INC. 2007-01-09 US disclosed
US-20060111582-A1 Process for arylamine production XEROX CORPORATION (US) 2006-05-25 US disclosed
WO-2005005520-A2 ACTIVE MASTERBATCH FOR PRODUCTION OF CO2 GENERATING MASTERBATCH CO2 TECHNOLOGIES, INC. (US) 2005-01-20 WO disclosed
US-20050001204-A1 Active masterbatch for production of CO2 generating masterbatch CO2 TECHNOLOGIES, INC. (US) 2005-01-06 US disclosed
WO-2004110876-A2 CO2 GENERATING ABSORBENT PADS CO2 TECHNOLOGIES, INC. (US) 2004-12-23 WO disclosed
US-20040247750-A1 CO2 generating absorbent pads CO2 TECHNOLOGIES, INC. 2004-12-09 US disclosed
US-6797235-B2 Device and methods for modifying an atmosphere CO2 TECHNOLOGIES, INC. 2004-09-28 US disclosed
WO-2004022112-A1 DEVICE AND METHODS FOR MODIFYING AN ATMOSPHERE CO2 TECHNOLOGIES, INC. (US) 2004-03-18 WO disclosed
US-20040047760-A1 Device and methods for modifying an atmosphere LONGER SHELF LIFE, LLC 2004-03-11 US disclosed
JP-H06271502-A ANTIMICROBIAL COMPOUND NITTO KASEI CO LTD 1994-09-27 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111582-A1 Process for arylamine production AOC2, UFM1, TYR BID 3728/4885MCL1 3212/4885BCL2L1 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.